AMLX
NASDAQ · Pharmaceuticals
Amylyx Pharmaceuticals Inc
$14.73
-0.47 (-3.09%)
Open$15.20
Previous Close$15.20
Day High$15.46
Day Low$14.51
52W High$18.61
52W Low$4.20
Volume—
Avg Volume1.04M
Market Cap1.68B
P/E Ratio—
EPS$-1.55
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+152.2% upside
Current
$14.73
$14.73
Target
$37.15
$37.15
$28.49
$37.15 avg
$49.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 140.51M | 449.35M | 403.13M |
| Net Income | -485,264,659 | 64.17M | 62.78M |
| Profit Margin | -345.4% | 14.3% | 15.6% |
| EBITDA | -506,644,708 | 107.91M | 96.37M |
| Free Cash Flow | — | 81.20M | 53.03M |
| Rev Growth | +574.3% | +13.9% | +9.9% |
| Debt/Equity | — | 0.29 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |